-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Encompass Health, Raises Price Target to $150

Benzinga·10/02/2025 11:57:15
Listen to the news
UBS analyst A.J. Rice maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $140 to $150.